Showing results (71-80 of 152) with videos related to

Sort By:
Pageof 16
BMC Cancer|November 14, 2018
Elevated platelet count is a negative predictive and prognostic marker in locally advanced rectal cancer undergoing neoadjuvant chemoradiation: a retrospective multi-institutional study on 965 patientsClaudio Belluco, Marco Forlin, Paolo Delrio, et al.
Biology|February 25, 2022
Clinical and Molecular Characteristics of Rare Malignant Tumors of Colon and RectumAlessandro Ottaiano, Mariachiara Santorsola, Francesco Perri, et al.
Techniques in Coloproctology|October 14, 2022
Short- and long-term outcomes in ypT2 rectal cancer patients after neoadjuvant therapy and local excision: a multicentre observational studyRoberto Peltrini, Simone Castiglioni, Nicola Imperatore, et al.
Surgical Innovation|May 19, 2017
Transanal Inspection and Management of Low Colorectal Anastomosis Performed With a New Technique: the TICRANT StudyFrancesco Crafa, Sebastian Smolarek, Giulia Missori, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|December 22, 2023
Completion total mesorectal excision after neoadjuvant radiochemotherapy and local excision for rectal cancerClaudio Coco, Paolo Delrio, Daniela Rega, et al.
International Journal of Radiation Oncology, Biology, Physics|May 18, 2010
Oxaliplatin plus dual inhibition of thymidilate synthase during preoperative pelvic radiotherapy for locally advanced rectal carcinoma: long-term outcomeAntonio Avallone, Paolo Delrio, Biagio Pecori, et al.
Plos One|January 7, 2017
Sequential PET/CT with [18F]-FDG Predicts Pathological Tumor Response to Preoperative Short Course Radiotherapy with Delayed Surgery in Patients with Locally Advanced Rectal Cancer Using Logistic Regression AnalysisBiagio Pecori, Secondo Lastoria, Corradina Caracò, et al.
Cancers|January 8, 2023
Colorectal Cancer with Peritoneal Metastases: The Impact of the Results of PROPHYLOCHIP, COLOPEC, and PRODIGE 7 Trials on Peritoneal Disease ManagementAntonio Sommariva, Marco Tonello, Federico Coccolini, et al.
Frontiers in Oncology|April 15, 2021
KRAS Mutational Regression Is Associated With Oligo-Metastatic Status and Good Prognosis in Metastatic Colorectal CancerAlessandro Ottaiano, Guglielmo Nasti, Mariachiara Santorsola, et al.
International Journal of Cancer|December 31, 2013
A prognostic model comprising pT stage, N status, and the chemokine receptors CXCR4 and CXCR7 powerfully predicts outcome in neoadjuvant resistant rectal cancer patientsCrescenzo D'Alterio, Antonio Avallone, Fabiana Tatangelo, et al.
Pageof 16